Drastic Response to Olaparib in a Patient With Metastatic Castration‐Resistant Prostate Cancer Harboring <scp>BRCA2</scp> Alterations and Near‐Threshold Tumor Mutational Burden

20260 citationsJournal Articlegold Open Access

Authors

In metastatic CRPC harboring a BRCA2 mutation and near-threshold TMB, olaparib produced clear radiological and serological responses.

Good health and well-being

Published in: IJU Case Reports

Volume 9, Issue 2, pp. e70144-e70144

Field-Weighted Citation Impact: 0.00